Literature DB >> 2791822

Serum levels of carbohydrate antigenic determinant (CA 19.9) in obstructive jaundice.

R Benamouzig, C Buffet, C Fourre, O Ink, F Moati, J P Etienne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2791822     DOI： 10.1007/bf01537129

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.

Authors:  T Yoshikawa; K Nishida; M Tanigawa; K Fukumoto; M Kondo
Journal:  Digestion       Date:  1985       Impact factor: 3.216

2.  Determination and significance of a new carbohydrate antigen CA19-9 in digestive system cancers.

Authors:  Y Arakawa; H Ariga; M Kano; Y Matsuo; T Honda; K Morita
Journal:  Jpn J Med       Date:  1985-05

3.  Elevated serum levels of tumor marker CA19-9 in acute cholangitis.

Authors:  M B Albert; W M Steinberg; J P Henry
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

4.  Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.

Authors:  H Jalanko; P Kuusela; P Roberts; P Sipponen; C A Haglund; O Mäkelä
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

5.  Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.

Authors:  R E Ritts; B C Del Villano; V L Go; R B Herberman; T L Klug; V R Zurawski
Journal:  Int J Cancer       Date:  1984-03-15       Impact factor: 7.396

6.  CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases.

Authors:  M Paganuzzi; M Onetto; P Marroni; D Barone; M Conio; H Aste; V Pugliese
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

7.  CA 19-9 and pancreatic adenocarcinoma.

Authors:  F Safi; H G Beger; R Bittner; M Büchler; W Krautzberger
Journal:  Cancer       Date:  1986-02-15       Impact factor: 6.860
  7 in total
  3 in total

1.  Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis.

Authors:  Y M Deugnier; A F Rabot; D Guyader; R Moirand; B Turlin; E Boucher; P Lebert; P Brissot
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

2.  Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.

Authors:  S L Ong; A Sachdeva; G Garcea; G Gravante; M S Metcalfe; D M Lloyd; D P Berry; A R Dennison
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

Review 3.  Fluorescent contrast agents for tumor surgery.

Authors:  Qi Xiao; Tianming Chen; Shilin Chen
Journal:  Exp Ther Med       Date:  2018-07-04       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.